The law is clear: no smoking in public, no sales by the stick. But on the ground, smoke drifts, and single sticks sell. Worse, the 2007 Act never foresaw vapes and flavoured nicotine products engineered to attract children.
Every morning in Kenya, as the sun rises over the skyline of Nairobi, a largely preventable public health tragedy continues to unfold. Tobacco use remains a significant contributor to mortality in the country. According to data from the Global State of Tobacco Harm Reduction, tobacco smoking was responsible for 9,418 deaths in Kenya in 2021, representing 2.63 per cent of all deaths nationally. When translated into daily estimates, this equates to about 26 tobacco-attributable deaths every day, or roughly one death each hour.
Despite Kenya implementing progressive tobacco control measures through the Kenya Tobacco Control Act 2007, tobacco-related diseases-including cardiovascular disease, cancers, and chronic respiratory illnesses-continue to impose a considerable burden on public health. This raises important questions about the effectiveness of policy implementation, enforcement mechanisms, and broader social and behavioural factors influencing tobacco consumption. The troubling reality is this: the laws exist; the evidence is overwhelming, and yet the dying continues.
Kenya’s Tobacco Control Act of 2007 was rightly celebrated as a gold standard for developing nations. It promised smoke-free public spaces, strict advertising bans, and unambiguous health warnings. Nearly two decades later, Thomas Lindi, CEO of the Kenya Tobacco Control Alliance, states a sobering truth: “Having good laws is one thing. Implementation is another.”
That gap between legislation and lived reality is the heart of the problem. Smoking zones remain poorly partitioned, allowing passive smoke to drift into communal areas. Bans on single-stick sales, which make cigarettes affordable to the young and the poor, are inconsistently enforced. The government is frequently perceived as accommodating the tobacco industry under the guise of economic diplomacy, and the industry has not been slow to exploit that accommodation.
Civil society has stepped into this enforcement vacuum with shadow reports-independent audits that document industry interference in real time, exposing lobbyists who dilute tax proposals and delay the introduction of graphic health warnings. These reports ensure that public health policy remains accountable to the people it is meant to protect, not to the commercial interests seeking to water it down.
An entire generation of nicotine delivery systems found themselves operating in a legal grey zone
The 2007 Act was drafted for a world of burning leaves. It could not have fully anticipated a market now defined by vapes, synthetic nicotine pouches, and flavoured devices engineered to attract children. Because the original legislation defined tobacco products primarily as items derived from tobacco leaf, an entire generation of nicotine delivery systems found themselves operating in a legal grey zone. The tobacco industry has exploited these regulatory gaps. By promoting modern oral nicotine pouches as safer alternatives, manufacturers have lobbied for preferential tax treatment despite growing public health concerns.
Studies by Prof Cyprian M. Mostert and other researchers on nicotine pouches and taxation, published in the Bulletin of WHO in 2024, indicate that those sold in Kenya contain high nicotine concentrations yet are subject to negligible taxation, with a 10 mg pouch retailing at about Ksh350 ($2.61) while attracting less than Ksh0.02 in tax. These products are frequently marketed in youth-appealing flavours, increasing the risk of early nicotine initiation.
Data cited in the same study indicate that about three per cent of primary school pupils in Kenya currently use tobacco products, highlighting the growing vulnerability of children to nicotine exposure. These products carry no trace of traditional cigarette smell, making them straightforward to conceal from parents and teachers. Packaged to resemble USB drives or high-end cosmetics, they are designed to normalise nicotine use before a child is old enough to understand what dependence means.
The health consequences of nicotine exposure are well established. Research shows that nicotine and tobacco emissions rapidly trigger oxidative stress and vascular inflammation, leading to endothelial dysfunction and the early development of atherosclerosis.
For young populations, this can translate into elevated blood pressure and premature cardiovascular strain. Additional studies demonstrate that exposure to e-cigarette aerosols can disrupt the oral microbiome, promoting jawbone loss and accelerated periodontal disease. Nicotine-induced vasoconstriction may further mask early symptoms, allowing tissue damage to progress unnoticed. These are not distant risks. They are accumulating in Kenyan schools and homes right now.
The World Health Organisation recommends that tobacco taxes reach at least 75 per cent of the retail price
The tobacco industry often portrays itself as a development partner, citing excise tax contributions as evidence of its economic value. However, this claim warrants scrutiny. According to the 2025 report, Economic Toll of Tobacco-Related Diseases in Kenya, tobacco use imposes an estimated healthcare cost of $396.1 million (Ksh53.4 billion) annually, reflecting the significant financial burden tobacco-related diseases place on the country’s health system and economy.
The World Health Organisation (WHO) recommends that tobacco taxes reach at least 75 per cent of the retail price to meaningfully deter consumption. Kenya currently sits between 70 per cent and 74 per cent. Closing that gap is the most direct mechanism available to price nicotine products out of the reach of young people. The industry’s contribution to the exchequer does not offset what it extracts from the health system, from families, and from the productive years of Kenyan lives.
For decades, litigation has been the tobacco industry’s most effective tool, not to win arguments on merit, but to exhaust regulatory momentum through prolonged legal attrition. In Kenya, that strategy has now met a firm boundary.
The Supreme Court of Kenya rejected a long-standing British American Tobacco (Kenya) appeal, validating the 2014 Tobacco Control Regulations and upholding Article 5.3 of the WHO Framework Convention on Tobacco Control-a global mandate insulating public health policy from commercial interference. The ruling established a legal firewall, requiring that government engagement with tobacco companies be limited, transparent and strictly regulatory in nature.
The Kenya Revenue Authority (KRA) is now empowered to investigate tax compliance and transfer pricing among industry players. The era in which corporate wealth could legally delay the protection of Kenyan citizens has, at least in principle, come to an end.
Graphic health warnings would cover 80 per cent of all packaging, vapes and pouches
Lawmakers are now revising the Tobacco Control Act with urgency that matches the scale of the problem. The proposed 2026 reforms seek to close the loopholes that have allowed next-generation nicotine products to operate without adequate regulation.
Definitions would be broadened to cover all nicotine-delivery systems regardless of their source. All characterising flavours would be prohibited. Online sales and social media marketing would face strict restrictions. Graphic health warnings would be required to cover at least 80 per cent of all packaging, vapes and pouches included.
Regionally, the momentum is encouraging. Somalia has moved to adopt stringent tobacco regulations, reducing the risk of regulatory arbitrage- the practice of relocating operations to weaker jurisdictions to funnel unregulated products back across borders. The East African Community is in discussions over a unified track-and-trace system designed to follow every pack from production to the retail shelf.
A nation’s productive future is secured by the health and capacity of its people
Kenya’s struggle with tobacco is not unique, but the choices Kenya makes in 2026 will have consequences that are distinctly its own. Traditional smoking rates have declined among older generations, but the industry’s calculated pivot towards youth-oriented, technology-driven nicotine products represents a deliberate attempt to secure the next generation of dependents. The response must match that ambition in scale and seriousness.
Legislation must be enforced, not merely drafted. Tax policy must reach the threshold that actually changes behaviour. Education must speak the language of the generation being targeted. And enforcement must happen at the shop counter and in the schoolyard, not just in courtrooms.
A nation’s productive future is secured by the health and capacity of its people. Every Kenyan life lost to a preventable tobacco-related illness is a family altered, a contribution never made, a future foreclosed. The industry has made its choice clear. It is time Kenya made its own.
Dr Madeline Iseren is a pharmacist who comments on topical health and medical issues.
